Inflammatory Epidermal Genodermatoses clinical trials

Explore recruiting inflammatory epidermal genodermatoses clinical trials.

Also recruiting in Europe

Inflammatory Epidermal Genodermatoses trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

GENEPID: A 44-weeks monocentric open study assessing the efficacy and safety of Deucravacitinib in adults with Inflammatory EPidermal GENodermatoses (epidermolysis bullosa simplex and inflammatory congenital ichthyoses)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Inflammatory Epidermal Genodermatoses trials by city

Inflammatory Epidermal Genodermatoses in Toronto Inflammatory Epidermal Genodermatoses in Vancouver Inflammatory Epidermal Genodermatoses in Montreal Inflammatory Epidermal Genodermatoses in Calgary Inflammatory Epidermal Genodermatoses in Edmonton Inflammatory Epidermal Genodermatoses in Ottawa Inflammatory Epidermal Genodermatoses in Winnipeg Inflammatory Epidermal Genodermatoses in Quebec City Inflammatory Epidermal Genodermatoses in Hamilton Inflammatory Epidermal Genodermatoses in Kitchener Inflammatory Epidermal Genodermatoses in London Inflammatory Epidermal Genodermatoses in Halifax Inflammatory Epidermal Genodermatoses in New York Inflammatory Epidermal Genodermatoses in Los Angeles Inflammatory Epidermal Genodermatoses in Chicago Inflammatory Epidermal Genodermatoses in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease